- United States
- United Kingdom
- France
- Australia
- Brazil
- Germany
- New Zealand
- Canada
- Spain
- Argentina
- India
- Netherlands
- Italy
- Sweden
- Puerto Rico
- Russia
- Egypt
- Mexico
- Belgium
- Greece
- Czechia
- Denmark
- Israel
- Thailand
- Ukraine
- Norway
- Poland
- Turkey
- Latvia
- Hungary
- Finland
- Croatia
- South Africa
- Ireland
- Kazakhstan
- Singapore
- Colombia
- Portugal
- Pakistan
- Tunisia
- Iceland
- Chile
- Lebanon
- Angola
- Switzerland
- United Arab Emirates
- Venezuela
- Peru
- Georgia
- Costa Rica
- Bolivia
- Romania
- Morocco
- Panama
- Japan
- Hong Kong
- Bulgaria
- China
- Austria
- Bosnia and Herzegovina
- Belarus
- Uruguay
- Estonia
- Ecuador
- South Korea
- Malaysia
- Bangladesh
- Jordan
- Lithuania
- Indonesia
- Iraq
- Philippines
- Kenya
- Sudan
- Vietnam
- Taiwan
- Iran
- Albania
- Honduras
- Slovenia
- Slovakia
- Paraguay
- Serbia
- Namibia
- Qatar
- Jamaica
- Malta
- Nigeria
- Macedonia
- El Salvador
- Moldova
- Guatemala
- Uzbekistan
- Dominican Republic
- Azerbaijan
- Algeria
- Luxembourg
- Nicaragua
- Sri Lanka
- Ivory Coast
- Kuwait
- Bermuda
- Cyprus
- Cambodia
- Laos
- Chad
- Macau
- Ghana
- Sierra Leone
- Senegal
- Random Picks
- Other Countries
The 48th Hour
PROBLEM: Every year, >80,000 severe MRSA infections occur in the U.S., resulting in over 11,000 deaths. Antibiotic resistance is growing and the need to treat these infections efficiently and effectively is more crucial than ever. But too often, irreparable damage has been done by the time more effective treatments are considered. SOLUTION: The CDC recommends that all clinicians review antibiotics 48 hours after initiated to see if the infection is responding. However, many HCPs leave patients on ineffective treatments for too long, causing irreparable damage or death. The48thHour.com drives awareness of the CDC guidelines and enforces the urgency to switch – no patient should be left on treatment without improvement after 48 hours. Digital advertisement created by FCB, United States for Theravance Biopharma, within the category: Pharmaceutical.